Archon Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.38M Sell
3,281,486
-15,258
-0.5% -$34.3K 6.05% 2
2025
Q1
$4.52M Buy
3,296,744
+156,463
+5% +$214K 4.76% 4
2024
Q4
$4.96M Buy
3,140,281
+25,000
+0.8% +$39.5K 4.82% 4
2024
Q3
$3.86M Hold
3,115,281
7.24% 4
2024
Q2
$4.17M Sell
3,115,281
-336,749
-10% -$451K 3.38% 10
2024
Q1
$4.69M Hold
3,452,030
1.62% 21
2023
Q4
$9.04M Hold
3,452,030
2.24% 14
2023
Q3
$11M Hold
3,452,030
2.9% 6
2023
Q2
$17.4M Hold
3,452,030
3.61% 4
2023
Q1
$9.94M Hold
3,452,030
2.23% 11
2022
Q4
$8.08M Buy
3,452,030
+757,781
+28% +$1.77M 2.34% 17
2022
Q3
$12.1M Buy
2,694,249
+31,336
+1% +$141K 2.15% 7
2022
Q2
$15.6M Buy
2,662,913
+329,324
+14% +$1.93M 3.57% 5
2022
Q1
$15.2M Buy
2,333,589
+139,471
+6% +$911K 1.88% 12
2021
Q4
$28.1M Sell
2,194,118
-44,397
-2% -$569K 3.7% 5
2021
Q3
$31M Sell
2,238,515
-210,887
-9% -$2.92M 4.38% 7
2021
Q2
$25.3M Hold
2,449,402
2.85% 5
2021
Q1
$23.7M Sell
2,449,402
-52,675
-2% -$509K 3.4% 6
2020
Q4
$18M Hold
2,502,077
3.11% 8
2020
Q3
$11.8M Buy
2,502,077
+19,195
+0.8% +$90.4K 2.37% 7
2020
Q2
$13.8M Sell
2,482,882
-112,000
-4% -$622K 2.96% 5
2020
Q1
$9.32M Sell
2,594,882
-95,144
-4% -$342K 3.43% 6
2019
Q4
$22.8M Sell
2,690,026
-50,000
-2% -$423K 3.86% 3
2019
Q3
$18.6M Sell
2,740,026
-54,400
-2% -$368K 4.37% 4
2019
Q2
$18.8M Buy
2,794,426
+1,267,754
+83% +$8.52M 3.44% 5
2019
Q1
$9.63M Sell
1,526,672
-453,038
-23% -$2.86M 2.63% 11
2018
Q4
$12.8M Sell
1,979,710
-44,300
-2% -$287K 5.23% 5
2018
Q3
$14.4M Sell
2,024,010
-242,028
-11% -$1.72M 5.63% 5
2018
Q2
$9.86M Hold
2,266,038
3.06% 7
2018
Q1
$6.73M Buy
2,266,038
+57,500
+3% +$171K 0.67% 7
2017
Q4
$5.74M Buy
2,208,538
+2,133,462
+2,842% +$5.55M 2.88% 11
2017
Q3
$254K Buy
+75,076
New +$254K 0.14% 23